NET INCOME (LOSS) PER COMMON SHARE (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
|---|
| Earnings Per Share [Abstract] |
|
| Schedule of Basic and Diluted Net Loss Per Share |
Basic and diluted net loss per share is calculated as follows (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, 2026 | | Shares | | Net Loss | | EPS | | Shares | | Net Loss | | EPS | | Continuing operations | 94,627,788 | | | $ | (61,037) | | | $ | (0.64) | | | 93,335,461 | | | $ | (132,436) | | | $ | (1.42) | | | Discontinued operations | 94,627,788 | | | $ | 8,700 | | | $ | 0.09 | | | 93,335,461 | | | $ | 8,200 | | | $ | 0.09 | | | Basic and diluted loss per share | 94,627,788 | | | $ | (52,337) | | | $ | (0.55) | | | 93,335,461 | | | $ | (124,236) | | | $ | (1.33) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | | | | | | | | | | | | September 30, 2025 | | Shares | | Net Income | | EPS | | Shares | | Net Loss | | EPS | | Basic income (loss) per share | 89,230,420 | | | $ | 25,706 | | | $ | 0.29 | | | 88,847,209 | | | $ | (28,275) | | | $ | (0.32) | | Interest expense associated with convertible debt, net of tax | | | 2,558 | | | | | | | | | | | Dilutive income (loss) per share | 102,618,560 | | | $ | 28,264 | | | $ | 0.28 | | | 88,847,209 | | | $ | (28,275) | | | $ | (0.32) | |
|
| Schedule of Weighted Average Number of Shares |
The calculation of diluted weighted average common shares outstanding for the three months ended September 30, 2025 was as follows: | | | | | | | Three Months Ended
September 30, 2025 | | Basic weighted average common shares outstanding | 89,230,420 | | | Dilutive common share equivalents - restricted stock units | 1,120,629 | | | Dilutive common share equivalents - convertible debt | 11,389,096 | | | Dilutive common share equivalents - options | 878,415 | | | Diluted weighted average common shares outstanding | 102,618,560 | |
|
| Schedule of Anti-dilutive Securities |
The following common stock equivalents have been excluded because they were anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Convertible debt | 11,065,704 | | | — | | | 10,521,096 | | | 11,593,869 | | | Options | 7,577,397 | | | 5,948,756 | | | 8,296,057 | | | 9,947,928 | | | Restricted stock units | 5,346,596 | | | 55,566 | | | 5,440,841 | | | 4,368,415 | | | | | | | | | | | Total anti-dilutive shares | 23,989,697 | | | 6,004,322 | | | 24,257,994 | | | 25,910,212 | |
|